Skip to main content
Livermore
Livermore
ZHEN

Boston Partners

SEC CIK
0001386060
Latest filing
Aug 4, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Boston Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
8,338
Value
$756.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by Boston Partners, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20268,338$756.0K<0.1%−8,019−49.0%ReducedHolders
Q1 202616,357$1.68M<0.1%−2,842−14.8%ReducedHolders
Q4 202519,199$2.41M<0.1%−1,676−8.0%ReducedHolders
Q3 202520,875$2.80M<0.1%−9,217−30.6%ReducedHolders
Q2 202530,092$4.09M<0.1%−3,107,794−99.0%ReducedHolders
Q1 20253,137,886$416.1M0.5%−541,794−14.7%ReducedHolders
Q4 20243,679,680$417.1M0.5%−53,184−1.4%ReducedHolders
Q3 20243,732,864$426.1M0.5%−57,823−1.5%ReducedHolders
Q2 20243,790,687$393.9M0.5%−18,361−0.5%ReducedHolders
Q1 20243,809,048$431.9M0.5%+36,378+1.0%AddedHolders
Q4 20233,772,670$415.9M0.6%+3,742,912+12,577.8%AddedHolders
Q3 202329,758$2.88M<0.1%+25,707+634.6%AddedHolders
Q2 20234,051$441.6K<0.1%+24+0.6%AddedHolders
Q1 20234,027$407.8K<0.1%−22−0.5%ReducedHolders
Q4 20224,049$444.5K<0.1%−13,085−76.4%ReducedHolders
Q3 202217,134$1.66M<0.1%−3,144−15.5%ReducedHolders
Q2 202220,278$2.20M<0.1%−1,777−8.1%ReducedHolders
Q1 202222,055$2.61M<0.1%−8,707−28.3%ReducedHolders
Q4 202130,762$4.33M<0.1%−7,169−18.9%ReducedHolders
Q3 202137,931$4.48M<0.1%−14,331−27.4%ReducedHolders
Q2 202152,262$6.06M<0.1%−45,076−46.3%ReducedHolders
Q1 202197,338$11.7M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.